MSP RECOVERY CLAIMS, SERIES, LLC v. SANOFI AVENTIS U.S. LLC

CourtDistrict Court, D. New Jersey
DecidedSeptember 6, 2024
Docket2:18-cv-02211
StatusUnknown

This text of MSP RECOVERY CLAIMS, SERIES, LLC v. SANOFI AVENTIS U.S. LLC (MSP RECOVERY CLAIMS, SERIES, LLC v. SANOFI AVENTIS U.S. LLC) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MSP RECOVERY CLAIMS, SERIES, LLC v. SANOFI AVENTIS U.S. LLC, (D.N.J. 2024).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

MSP RECOVERY CLAIMS SERIES, LLC, SERIES PMPI, MAO-MSO RECOVERY II, LLC, and MSPA CLAIMS 1, LLC,

Case No. 2:18-cv-02211 (BRM) (RLS) Plaintiffs,

OPINION v.

SANOFI-AVENTIS U.S. LLC, NOVO

NORDISK INC., and ELI LILLY AND COMPANY,

Defendants.

MARTINOTTI, DISTRICT JUDGE Before the Court is an appeal1 (ECF No. 418) by Plaintiffs MSP Recovery Claims Series, LLC, Series PMPI, MAO-MSO Recovery II, LLC, and MSPA Claims 1, LLC’s (collectively, “Plaintiffs”) of Special Master Dennis M. Cavanaugh, U.S.D.J. (ret.)’s (the “Special Master”) May 10, 2023 Order (ECF No. 361 (the “May 10, 2023 Order”)) and January 29, 2024 Order and Opinion Denying Plaintiff’s Motion for Reconsideration of the May 10, 2023 Order (ECF No. 417 (the “January 29, 2024 Order”)), pursuant to Federal Rule of Civil Procedure 53(f) and Paragraph 6 of the Stipulation Regarding Appointment of Special Master (ECF No. 1282). Defendants Sanofi-

1 Plaintiffs’ filing is titled “Objection to Special Master’s Orders” but was filed on the docket as a “Motion to Vacate” the Special Master’s May 10, 2023 Order and January 29, 2024 Order. (See ECF No. 418.) The Court construes Plaintiffs’ filing as an appeal from the Special Master’s May 10, 2023 Order and his January 29, 2024 Order denying Plaintiffs’ motion for reconsideration of his May 10, 2023 Order.

2 On October 22, 2020, this Court entered an order appointing The Honorable Dennis M. Cavanaugh, U.S.D.J. (ret.) as the Special Master in this action. (ECF No. 128.) That order set forth Aventis U.S. LLC, Novo Nordisk Inc., and Eli Lilly and Company (collectively, “Defendants”) filed an opposition to Plaintiff’s appeal. (ECF No. 424.) Plaintiffs filed a belated reply in further support of their appeal.3 (ECF No. 426.) Having reviewed the parties’ submissions filed in connection with this appeal and having declined to hold oral argument pursuant to Federal Rule of

Civil Procedure 78(b), for the reasons set forth below and for good cause having been shown, Plaintiffs’ appeal (ECF No. 418) is DENIED and the Special Master’s May 10, 2023 Order (ECF No. 361) and January 29, 2024 Order (ECF No. 417) are AFFIRMED. I. BACKGROUND This matter has been ongoing since 2018, and the factual and procedural backgrounds of this matter are well-known to the parties and were previously recounted by the Court in its prior opinions: (1) granting in part and denying in part Defendants’ Motion to Dismiss Plaintiffs’

the briefing schedule in the event any party objected to the Special Master’s orders. (Id. ¶ 6.) Pursuant to the order, parties were permitted to “object to, move to adopt, or move to modify” an order of the Special Master within fourteen (14) days of the order’s entry on CM/ECF. (Id.) A party opposing the objection or motion is required to file a responsive brief within fourteen (14) days of the objection or motion’s filing, and the moving party “may file a reply to an opposition within seven (7) days of the day the opposition was filed.” (Id.) The order further provides that “[t]he Special Master’s decision resolving any dispute may be appealed to Judge Martinotti in the same manner—and subject to the same deadlines and standards of review—as a decision of a Magistrate Judge, in accordance with Local Civil Rule 72.1(c)(1) and Federal Rule of Civil Procedure 53(f)(3)−(5).” (Id.)

3 Both Plaintiffs’ appeal and reply in further support of their appeal were untimely filed. The Special Master’s Order and Opinion denying Plaintiffs’ motion for reconsideration was filed on January 29, 2024. (ECF No. 417.) Plaintiffs filed untimely objections to the January 29, 2024 Order on February 13, 2024 (see ECF No. 418), one day after the fourteen-day deadline to file such objections (see supra n.2), which Plaintiffs concede (see ECF No. 426 at 3 n.1). Defendants timely filed an opposition to Plaintiffs’ objections on February 27, 2024. (ECF No. 424.) Plaintiffs then filed an untimely reply on March 11, 2024 (ECF No. 426), six days after the seven-day deadline to file a such a reply (see supra n.2). Plaintiffs did not seek leave of Court to file belated objections or a belated reply to the Special Master’s orders. However, because the Court prefers to decide issues on the merits rather than dismissing on a technicality, the Court will consider both of Plaintiffs’ untimely filings for the purposes of this appeal, but the Court reminds Plaintiffs that they must timely submit any such filings that may be filed in this matter in the future. Amended Complaint (ECF No. 89), and (2) granting in part and denying in part Defendants’ Motion to Dismiss Plaintiffs’ Second Amended Complaint (ECF No. 111). Therefore, the Court only includes the facts and procedural background relevant to this appeal. Plaintiffs are entities who have been assigned claims from 57 Medicare Advantage Plans

and Defendants are manufacturers of insulin products. (ECF No. 150 at 2.) The litigation involves allegations that Plaintiffs incurred damages resulting from overpayments made on behalf of the plans’ beneficiaries for insulin products manufactured by Defendants. (Id.) This appeal arises from a discovery dispute between Plaintiffs and Defendants. On May 10, 2023, the Special Master issued the May 10, 2023 Order addressing various discovery disputes between Plaintiffs and Defendants after hearing oral argument on these disputes at the May 5, 2023 conference. (See generally ECF No. 361.) Plaintiffs object to the Special Master’s rulings on Issue 2 and Issue 4 in the May 10, 2023 Order.4 (See ECF Nos. 361, 418, 426.) Issue 2 involved whether Plaintiffs “are required to file a statement concerning litigation funding as set forth in Local Rule 7.1.1” (“Issue 2”). (ECF No. 361 at 1.) Defendants argued Plaintiffs were

required to file a Rule 7.1.1 statement, but Plaintiffs denied such a statement is required in this matter (“Issue 2”). (Id.) In the May 10, 2023 Order, the Special Master ordered Plaintiffs “to either submit a Local Rule 7.1.1 Statement or a certification setting forth why such a statement is unnecessary in this matter.” (Id. at 3.) Plaintiffs chose the latter option and filed a letter attaching a certification from Plaintiffs’ designated corporate representative, which states Plaintiffs “have not received any third-party litigation funding on a non-recourse basis necessitating disclosure” pursuant to Local Civil Rule 7.1.1 (the “Lopez Certification”). (See ECF No. 362.)

4 Accordingly, the Court focuses on these two discrete issues to which Plaintiffs object, relevant to this appeal, and does not address the other issues addressed in the May 10, 2023 Order. Issue 4 involved whether Plaintiffs had to produce certain additional documents in discovery including but not limited to “marketing materials” and “agreements and funding documents with litigation funders” (“Issue 4”). (ECF No. 361 at 2.) In a letter dated April 20, 2023 (the “April 20, 2023 Letter”), Defendants identified four categories of relevant documents

allegedly missing from Plaintiffs’ custodial document production and requested Plaintiffs produce those documents, which included “corporate formation documents, marketing materials, agreements and funding documents with litigation funders, and nonresponsive slipsheets.” (Id.; ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. United States Gypsum Co.
333 U.S. 364 (Supreme Court, 1948)
Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)
United States v. Raddatz
447 U.S. 667 (Supreme Court, 1980)
Anderson v. City of Bessemer City
470 U.S. 564 (Supreme Court, 1985)
Goodman v. Wagner
553 F. Supp. 255 (E.D. Pennsylvania, 1982)
Gunter v. Ridgewood Energy Corp.
32 F. Supp. 2d 162 (D. New Jersey, 1998)
Kounelis v. Sherrer
529 F. Supp. 2d 503 (D. New Jersey, 2008)
Marks v. Struble
347 F. Supp. 2d 136 (D. New Jersey, 2004)
United States v. Robert Waterman
755 F.3d 171 (Third Circuit, 2014)
Younes v. 7-Eleven, Inc.
312 F.R.D. 692 (D. New Jersey, 2015)
Roesberg v. Johns-Manville Corp.
85 F.R.D. 292 (E.D. Pennsylvania, 1980)

Cite This Page — Counsel Stack

Bluebook (online)
MSP RECOVERY CLAIMS, SERIES, LLC v. SANOFI AVENTIS U.S. LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/msp-recovery-claims-series-llc-v-sanofi-aventis-us-llc-njd-2024.